Multicenter, Observational Study to Evaluate NeoRecormon Treatment in Anemic Patients Suffering From Non-myeloid Malignancy Receiving Chemotherapy
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Anemia
Both
Anemia
Trial Information
Multicenter, Observational Study to Evaluate NeoRecormon Treatment in Anemic Patients Suffering From Non-myeloid Malignancy Receiving Chemotherapy
Inclusion Criteria:
- Adult patients, >/=18 years of age
- Presence of solid-tumor or non-myeloid malignancy
- Patients receiving chemotherapy
- Eastern Cooperative Oncology Group (ECOG) Performance status 0-2
- Patients require NeoRecormon
Exclusion Criteria:
- Hypersensitivity to the drug
- Uncontrolled hypertension
- Female patients if pregnant and/or lactating
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Response rate: Change in HB level
Outcome Time Frame:
From baseline to week 8
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Hungary: National Institute of Pharmacy
Study ID:
ML25362
NCT ID:
NCT01716559
Start Date:
August 2010
Completion Date:
March 2012
Related Keywords:
- Anemia
- Anemia
Name | Location |
|---|
